Recruiting The GBA Multimodal Study in Parkinson's Disease NCT04101968 Conditions Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +21 more Locations Oregon Health & Science University — Portland, Oregon, United States University of Washington — Seattle, Washington, United States Pacific Parkinson's Research Centre | University of British Columbia — Vancouver, British Columbia, Canada View Trial Details
Recruiting Drug Discovery for Parkinson's With Mutations in the GBA Gene NCT05536388 Conditions Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +22 more Locations The New York Stem Cell Foundation Research Institute — New York, United States View Trial Details
Completed Ambroxol as a Disease-modifying Treatment in GBA-PD NCT05287503 Conditions Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more Locations Fondazione IRCCS Istituto Neurologico Carlo Besta — Milan, Italy University of Campania "Luigi Vanvitelli" — Naples, Italy IRCCS National Neurological Institute "C. Mondino" Foundation — Pavia, Italy View Trial Details
Completed LRRK2, GBA and Other Genetic Biomarkers in Eastern European (Ashkenazi) Jews With and Without Parkinson's Disease NCT04668898 Conditions Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +8 more Locations Mount Sinai-- Downtown Union Square — New York, United States View Trial Details
Completed Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers NCT03234478 Conditions Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +19 more Locations Rutgers-Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States View Trial Details
